Click image to zoom

Ozempic Maker Novo Nordisk Set To Surpass LVMH As Most Valuable European Company

A hand holding an Ozempic needle injection pen is seen silhouetted against small lights in this illustration photo in Warsaw, Poland on 03 September, 2023. (Photo by Jaap Arriens/NurPhoto)

Photo Details

Photo ID	#10462312
Date Taken	3 September 2023
Location	N/A
Photographer	Jaap Arriens/NurPhoto
Category	Economy, Business and Finance
Copyright	© 2025 NurPhoto - Jaap Arriens/NurPhoto

Related Keywords

Novo Nordisk Ozempic Poland Polska Rybelsus Semaglutide Warsaw Warszawa Wegovy antidiabetic brand branding diabetes care diabetes management diabetes medication diabetes support diabetes treatment editorial photography fat loss health healthcare healthcare advancements healthcare photography healthcare technology injection insulin medical equipment medical innovation medical procedure medication medication administration medicine needle needle injection patient treatment pen pharmaceutical pharmaceuticals subcutaneous injection hand Ozempic needle injection pen Warsaw Poland 03 September 2023 Jaap Arriens/NurPhoto

License This Photo

Digital Basic Editorial use on digital platforms only (websites, social media). Single use, up to 1 million monthly UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€35.00

Editorial Print & Digital For editorial use in print and digital publications such as newspapers, magazines, and textbooks. Single use, up to 10,000 copies or 1 million UVs. Worldwide distribution. NO COMMERCIAL OR PROMOTIONAL USE

€99.00

Broadcast (TV & Digital) For editorial use in TV production or streaming platforms. Single use, all media rights excluding theatrical, with worldwide distribution in perpetuity. NO COMMERCIAL OR PROMOTIONAL USE

€399.00

Total Price

€35.00

Secure checkout

Need a custom license?

Contact Sales